REGN - CIK 0000872589
REGENERON PHARMACEUTICALS, INC. has filed 985 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (631 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2023-07-06 | 2023-07-03 |
| Insider trade | 4 | 2023-07-06 | 2023-07-03 |
| Insider sale notice | 144 | 2023-07-03 | - |
| Insider sale notice | 144 | 2023-07-03 | - |
| Major company event | 8-K | 2023-06-14 | 2023-06-09 |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider sale notice | 144 | 2023-06-01 | - |
| Shareholder proxy notice | PX14A6G | 2023-05-18 | - |
| Insider trade | 4 | 2023-05-17 | 2023-05-15 |
| Proxy materials | DEFA14A | 2023-05-17 | - |
| Insider trade | 4 | 2023-05-10 | 2023-05-09 |
| Quarterly report | 10-Q | 2023-05-04 | 2023-03-31 |
| Major company event | 8-K | 2023-05-04 | 2023-05-04 |
| Insider trade | 4 | 2023-05-03 | 2023-05-01 |
| Insider trade | 4 | 2023-04-24 | 2023-04-21 |
| Insider sale notice | 144 | 2023-04-21 | - |
| Proxy materials | DEFA14A | 2023-04-21 | - |
| Proxy statement | DEF 14A | 2023-04-21 | - |
| Annual report to shareholders | ARS | 2023-04-21 | 2022-12-31 |
| Major company event | 8-K | 2023-04-17 | 2023-04-14 |
| Major company event | 8-K | 2023-04-10 | 2023-04-10 |
| Insider trade | 4 | 2023-04-05 | 2023-04-03 |
| Insider trade | 4 | 2023-04-05 | 2023-04-03 |
| Insider trade | 4 | 2023-04-05 | 2023-04-03 |
| Insider trade | 4 | 2023-03-29 | 2023-03-27 |
| Major company event | 8-K | 2023-03-29 | 2023-03-27 |
| Insider trade | 4 | 2023-03-27 | 2023-03-24 |
| Insider trade | 4 | 2023-03-27 | 2023-03-23 |
| Insider trade | 4 | 2023-03-27 | 2023-03-23 |
| Insider trade | 4 | 2023-03-27 | 2023-03-23 |
| Insider trade | 4 | 2023-03-27 | 2023-03-23 |
| Insider trade | 4 | 2023-03-14 | 2023-03-10 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Insider trade | 4 | 2023-03-03 | 2023-03-01 |
| Insider trade | 4 | 2023-02-24 | 2023-02-22 |
| Insider trade | 4 | 2023-02-14 | 2023-02-12 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-02-09 | - |
| Insider trade | 4 | 2023-02-08 | 2023-02-06 |
| Insider trade | 4 | 2023-02-08 | 2023-02-06 |
| Insider trade | 4 | 2023-02-08 | 2023-02-06 |
| Insider trade | 4 | 2023-02-08 | 2023-02-07 |
| Insider trade | 4 | 2023-02-07 | 2023-02-03 |
| Insider trade | 4 | 2023-02-07 | 2023-02-03 |
| Insider trade | 4 | 2023-02-07 | 2023-02-03 |
| Annual report | 10-K | 2023-02-06 | 2022-12-31 |
| Insider trade | 4 | 2023-02-03 | 2023-02-01 |
| Insider trade | 4 | 2023-02-03 | 2023-02-01 |